Core Viewpoint - The article emphasizes the importance of innovation in the medical device industry, particularly in the surgical stapler market, where a Chinese company, Tianchen Medical, is breaking the long-standing monopoly of international giants through self-innovation and a focus on affordability and accessibility [1][4]. Company Overview - Tianchen Medical, established in 2003, specializes in high-end surgical staplers and has developed a product system covering five categories across various fields such as cardiothoracic, gastrointestinal, and general surgery [1][6]. - In the first three quarters of the year, the company achieved revenue of 244 million yuan and a net profit of 71.95 million yuan, representing year-on-year growth of 20.66% and 68.29%, respectively [1]. Innovation and Product Development - The TST series stapler, designed for prolapse surgery, allows the procedure to be completed with a single device, significantly reducing operational difficulty and medical costs [2][6]. - Tianchen Medical employs a co-creation research and development model, involving frontline clinical doctors in the design process to address real clinical pain points [2][5]. Market Dynamics - The surgical stapler market was previously dominated by a few international giants, with prices around 20,000 yuan and profit margins exceeding 90%, making it unaffordable for many patients [4][7]. - The lack of effective competition led to a stagnation in innovation, with no core patent breakthroughs in nearly a decade [4]. Patent Strategy - Tianchen Medical has developed a "jungle-style" patent strategy to navigate the complex patent landscape dominated by international competitors, resulting in a robust intellectual property defense [5][6]. - As of mid-2025, the company holds 822 patents globally, including 565 invention patents, successfully breaking the long-standing intellectual property monopoly in the field [6]. Competitive Positioning - The company’s technology has reached parity with international giants, leading to a significant reduction in the price of staplers from nearly 20,000 yuan to about one-tenth of that, making technology more accessible [7]. - Tianchen Medical's self-developed laparoscopic stapler products are now competitive with international counterparts, reducing surgical trauma and enabling new surgical techniques [7]. Future Directions - The company is focusing on the next phase of development in surgical robotics, aiming to create an open, standardized intelligent surgical platform rather than a closed, high-cost system [8][9]. - This approach aims to enhance the accessibility and affordability of surgical robotics, contributing to a more sustainable and innovative medical environment [9].